This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Substance withdrawal
From PsychonautWiki Archive
Revision as of 06:45, 4 May 2017 by >Fishcenternicole(added ontop opioid WD and cannabis WD)
Drug withdrawal is a group of symptoms that occur upon the abrupt discontinuation or decrease in one's intake of a substance. Withdrawal develops after a physical or mental dependence, which is caused by consuming substances for an extended period of time. It is dose dependent and varies based upon the drug consumed, the duration of intake, as well as the route of administration used.
Each drug causes its own specific symptoms with opioid withdrawals causing significantly different symptoms than benzodiazepine withdrawal, for instance. The term "cold turkey" is used to describe the sudden cessation use of a substance and the ensuing physiologic manifestations. It is recommended that users taper their dose slowly over time instead of abruptly stopping, which is associated with higher rates of relapse.[citation needed]
Withdrawal symptoms are commonly reported following abuse of opioids (such as heroin, hydrocodone, or oxycodone) over an extended period of time. They are also present with the newer brand of research chemicals such as U-47700 and fentanyl analogs. Withdrawal is not expected to occur in opioid-naive individuals or those who use infrequently, as it is caused by the down-regulation of opioid receptors in response to repeated usage. The experience of opioid withdrawal is often described as being "flu-like" in nature and includes rebound sensitivity to pain and tactile stimulation.
Opioids with a short half-life, such as diacetylmorphine (heroin) are well known to induce withdrawal symptoms in tolerant individuals within several hours of having cleared the body. Longer eliminating opioids like methadone will exhibit symptoms of withdrawal much later, but the effects will linger far in excess of shorter acting opioids. Faster eliminating opioids like Fentanyl and U47700 will exhibit the symptoms of withdrawal much quicker, but the effects will subside faster than longer acting opioids such as heroin.
Withdrawal symptoms from opiate abuse include (but are not limited to):
Skin-crawling - This is distinct from the goosebumps experienced in withdrawal because the skin crawling sensation feels like something is distinctly moving under the skin.
Goosebumps - These are raised areas on the skin[2] that can appear and disappear suddenly.
Dilated pupils - These are a stark contrast to the constricted pupils one sees in active opiate abusers and can be a hallmark of opiate withdrawalCite error: Closing </ref> missing for <ref> tag The mechanism which underlies this process involves a decrease responsiveness of GABA receptors in the brain.
Due to the risk of seizures or delirium tremens, alcohol withdrawal can be fatal depending on the severity of usage. It is recommended to taper one's dosage and to seek medical attention and begin treatment as soon as possible.
Seizures[3] - In severe cases, this can result in death. Seizures typically occur within 48 hours of the abrupt discontinuation of alcohol and occur either as a single generalized tonic-clonic seizure or as a brief episode of multiple seizures.[4]
Delirium tremens - This is the rapid onset of delirium, confusion, hallucinations, and other symptoms associated with alcoholwithdrawal caused by the abrupt discontinuation in long-term/heavy users. Delirium tremens are a cluster of symptoms, which can be potentially fatal. Delirium tremens usually occur three days after discontinuation and can last up to three days. It is reported that they are characteristically worse at night. Anyone thought to be suffering from the condition requires immediate medical intervention due to the risk of death, with the mortality without treatment being between 15% and 40%.[5]
Wernicke syndrome - This is condition characterized by extreme confusion, an abnormal gait, and the paralysis of muscles in the eye. This condition occurs only in severe alcohol withdrawal cases. Wernicke syndrome can progress into irreversible dementia so anyone suspected of this should seek immediate medical attention and be treated with 100mg of thiamine daily while withdrawling.[6]
Treatment
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. It is inadvisable to self-administer a taper; the remaining alcohol should be given to a trusted friend or family member and distributed by only them.
Vitamins such as thiamine[8], folic acid, and pyridoxine - These vitamins are often recommended because those dependent on alcohol are often deficient in nutrients; in very severe cases, this can result in Wernicke syndrome, which is a condition characterized by extreme confusion, an abnormal gait, and the paralysis of muscles in the eye. Wernicke syndrome can progress into irreversible dementia so anyone suspected of this should seek immediate medical attention and be treated with 100mg of thiamine daily while withdrawling.
Magnesium - Although it has not been verified, there may be a causal relationship between low magnesium levels and withdrawal seizures or delirium.[6]
Anticonvulsants such as topiramate, pregabalin, or gabapentin - There is some limited evidence that topiramate, pregabalin, or gabapentin could help alcohol withdrawal; however, gabapentin is not recommended for severe withdrawal.[9][10]
Haloperidol - The antipsychotic haloperidol may also be used to control symptoms, especially agitation or psychosis. However, antipsychotics lower the seizure threshold so they can potentially worsen the withdrawal.
Paraldehyde - This is an older drug that is generally not used anymore. In regards to treating severe and fatal withdrawal symptoms, paraldehyde combined with chloral hydrate showed superior results over chlordiazepoxide.[11]
Acamprosate - This drug is sometimes used in addition to other treatments. It can be continued long-term to reduce the risk of relapse.
Carbamazepine - This drug assisted in the reduction of withdrawal symptoms in seven scientific trials involving 612 patients.[6] However, it is questionable whether or not the drug can prevent seizures and delirium tremens in a similar manner to benzodiazepines due to inconclusive evidence.
Clonidine - This drug is sometimes combined with benzodiazepines to treat symptoms.
Nicotine withdrawal
While nicotine withdrawal may cause some withdrawal effects, it is not life-threatening. However, the mental cravings which it can induce can be as intense as other addictive drugs such as alcohol.
The effects generally begin 2-3 hours after cessation, peak in 2-3 days, and last 2-4 weeks.
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's intake of nicotine over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. This may be very difficult for some individuals and many prefer to quit cold turkey.
Nicotine replacement therapy - This stops withdrawal symptoms by providing the body with an alternative source of nicotine. NRT is available in numerous forms and includes nicotine chewing gum, adhesive patches, lozenges, and nasal sprays.[12] Combining different forms is shown to be more effective than only using one form.[13][14] Generally, the user is encouraged to later taper one's new nicotine intake after several weeks.
Bupropion (Wellbutrin) - This is a medication primarily used as an antidepressant and smoking cessation aid, reducing the intensity of nicotine cravings and its withdrawal symptoms. It acts as an norepinephrine-dopamine reuptake inhibitor (NDRI). It doubles the chance of quitting smoking successfully, making its effectiveness comparable to nicotine replacement therapy but less effective than varenicline.[15]
Varenicline (Chantix) - This prescription medication is a nicotinic receptor partial agonist which is similar to cytisine and works to reduce cravings by stimulating nicotine receptors more weakly than nicotine itself does. It also decreases the euphoric effects of cigarettes and other nicotine products.
Cytisine - This drug is a partial agonist of nicotinic acetylcholine receptors (nAChRs), which is similar to varenicline.
Exercise - Non-medications treatments such as increased exercise can also reduce nicotine withdrawal.
NAC - In terms of reducing cravings, NAC has been shown to provide relief for those who struggle with compulsive redosing and psychological cravings.
Other medications used for quitting smoking include nortriptyline and clonidine. Many behavior changes such as avoiding situations where one usually smoked, planning ahead to deal with temptations, and seeking the support of friends and family are effective in helping people quit smoking, but whether this is due to reduced withdrawal is unclear.
Benzodiazepine withdrawal
Due to the risk of seizures, benzodiazepine withdrawal can be fatal depending on the severity of usage. It is recommended to taper one's dosage, and seek medical attention to begin treatment as soon as possible if one has been using for a long time or is experiencing severe symptoms. Short-acting benzodiazepines usually present withdrawal symptoms after 24 to 48 hours; however, it can take a couple weeks for the symptoms of longer lasting ones to appear.
A small minority of users who abuse benzodiazepines for extended periods of time may develop post-acute-withdrawal syndrome, which may last for months or years after stopping usage.
The following symptoms may emerge during gradual or abrupt dosage reduction:
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. It is inadvisable to self-administer a taper; the remaining substance should be given to a trusted friend or family member and distributed by only them.
Phenibut - Switching to another GABAergic can lessen the perceived symptoms, but is likely to also prolong the period of withdrawal and could potentially lead to addiction.
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. It is inadvisable to self-administer a taper; the remaining substance should be given to a trusted friend or family member and distributed by only them.
Cannabis withdrawal
Although not medically serious, cannabis withdrawal symptoms can occur in users who have been using the drug for an extended period of time. In comparison to most other drugs, cannabis withdrawal is very mild. Most symptoms begin during the first week of abstinence and resolve after a few weeks. These symptoms include:
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. It is inadvisable to self-administer a taper; the remaining substance should be given to a trusted friend or family member and distributed by only them.
Dronabinol - Dronabinol is an agonist that is legally available; in some cases and trials, it reduced symptoms of withdrawal and reduced cannabis use.[21]
Diphenhydramine (DPH) - This drug can assist with sleep if one has insomnia, but may also exacerbate the restlessness of withdrawal in high does.
Benzodiazepines - As benzodiazepines have a high risk of addiction, one should be careful not to become physically dependent on them.
Exercise - This may reduce some symptoms and accelerates the rate that THC exits the body by releasing the THC metabolites stored in the fat tissue into the blood stream[22].
N-Acetylcysteine (NAC) - In terms of reducing cravings, NAC has been shown to provide relief for those who struggle with compulsive redosing and psychological cravings with cocaine, and has been singled out with gabapentin as a promising potential treatment for cannabis-dependent users.[23][24]
Gabapentin - Early, preliminary evidence suggests that gabapentin is capable of reducing withdrawal symptoms and relapse rates in cannabis-dependent adults who seek to quit. However, larger confirmatory studies are still required.[25]
Caffeine withdrawal
Research has suggested that withdrawals start between 12 to 24 hours after the abrupt discontinuation of caffeine and may last up to nine days.[26]
Caffeine dependence can involve withdrawal symptoms such as:
Headaches - In one study, it was found that headaches were experienced by half of the participants who stopped consuming 235mg of caffeine on average daily for two days.[27]
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. The amount of caffeine present in a drink is usually written on the nutrition facts or is searchable online. For an easy taper, buy caffeine pills and then divide the doses into halves and eventually quarters using a pill cutter. If you are unable to control yourself from dosing too high, the remaining substance should be given to a trusted friend or family member and distributed by only them.
Over-the-counter painkillers - Painkillers such as naproxen, aspirin, acetaminophen, or ibuprofen can reduce withdrawal symptoms such as headaches and lessen any muscle or joint pain. Some OTC products include caffeine alongside painkillers, which can be used to self-administer a taper.
Gradually tapering one's intake - Withdrawal symptoms can be reduced by slowly lowering one's dosage over a period of days or weeks, which will let receptors recover somewhat before complete discontinuation. This will lessen the severity of symptoms but likely prolong their duration. It is inadvisable to self-administer a taper; the remaining substance should be given to a trusted friend or family member and distributed by only them.
NAC - In terms of reducing cravings, NAC has been shown to provide relief for those who struggle with compulsive redosing and psychological cravings.
↑Stern, TA; Gross, AF; Stern, TW; Nejad, SH; Maldonado, JR (2010). "Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".". Primary care companion to the Journal of clinical psychiatry. 12 (3). doi:10.4088/PCC.10r00991ecr. PMID 20944765. | https://www.ncbi.nlm.nih.gov/pubmed/20944765
↑Hammond, CJ; Niciu, MJ; Drew, S; Arias, AJ (April 2015). "Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders". CNS Drugs. | https://www.ncbi.nlm.nih.gov/pubmed/25895020
↑ung, JG; Hall-Flavin, D; Nelson, S; Schmidt, KA; Schak, KM (August 2015). "The role of gabapentin in the management of alcohol withdrawal and dependence". The Annals of Pharmacotherapy (Review). | https://www.ncbi.nlm.nih.gov/pubmed/25969570
↑alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo]. | https://www.ncbi.nlm.nih.gov/pubmed/9850822
↑Echevarria, M. A. N., Reis, T. A., Capatti, G. R., Soares, V. S., da Silveira, D. X., & Fidalgo, T. M. (2017). N-acetylcysteine for treating cocaine addiction – A systematic review. Psychiatry Research. 251, 197-203. https://doi.org/10.1016/j.psychres.2017.02.024
↑Sherman, B. J., & McRae‐Clark, A. L. (2016). Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(5), 511-535. https://doi.org/10.1002/phar.1747
↑Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., ... & Rao, S. (2012). A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology, 37(7), 1689-1698. https://doi.org/10.1038/npp.2012.14
↑ffiths, R. R. (2004). "A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features". Psychopharmacology. | https://www.ncbi.nlm.nih.gov/pubmed/15448977